Traws Pharma, Inc. (TRAW) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

Compression note: triangle compression is around 46%, so resolution moves may become sharper as the structure tightens.

📊 Technical Summary

Traws Pharma, Inc. (TRAW) finished the session at 1.43 (+10.00%). With price below both the 50-day and 200-day moving averages, the broader structure still reflects elevated technical pressure. 20-day momentum is notably weak at -13.86%, with price is trading in the lower part of its roughly 52-week range (1.09–3.13), while ATR14 volatility is elevated at roughly 12.99% of price. RSI(14) is 48.4, leaving momentum in a fairly neutral range. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains above its signal line, which keeps the momentum structure biased to the upside. The MACD histogram is positive and expanding, pointing to improving upside momentum. Nearby upside pressure sits around 1.60. A decisive move through that level would improve the short-term picture. On the fundamentals side, the latest snapshot shows Revenue: 2.79M · Net income: -3.96M · EPS (basic): -0.34. For a fuller technical read, the interactive view adds overlays, pattern context and broader chart structure.

Explore more